Results 91 to 100 of about 10,278,879 (215)

Experimental myocardial damage affected the administration of D-penicillamine. [PDF]

open access: yes, 2018
Charles University in Prague, Faculty of Pharmacy in Hradec Králové Department of Biological and Medical Sciences Candidate: Bc. Edita Blažková Supervisor: doc. RNDr. Vladimír Semecký, CSc.
Blažková, Edita
core  

Effect of oral d-penicillamine vs. colchicine on experimentally induced peritoneal adhesions in rats

open access: yes, 2007
To evaluate the effects of d-penicillamine on prevention or reduction of adhesion band formation and to compare its effects with those of colchicine in an animal model. A prospective experimental study. Rats in an academic research environment.
Nikeghbalian, Saman   +5 more
core   +1 more source

The treatment of rheumatoid arthritis with D-penicillamine. Preliminary report

open access: yes, 1978
Twenty patients with classical or definite rheumatoid arthritis were treated with D-Penicillamine. Favorable responses were observed in 75% of the patients. Significant improvement in clinical parameters, such as ESR, CRP, titers of rheumatoid factor and
Takasugi, Kiyoshi   +3 more
core   +1 more source

Nephrotic Syndrome after Treatment with D-Penicillamine in a Patient with Wilson’s Disease- A Case Report

open access: yes, 2016
We report a case with Wilson’s disease who developed nephrotic syndrome one year after starting D-pencillamine. After stopping D-penicillamine, only zinc was given for maintenance.
Akter, AHM Muslima   +5 more
core   +1 more source

D-Penicillamine inhibits transactivation of human immunodeficiency virus type-1 (HIV-1) LTR by transactivator protein

open access: yes, 1988
D-Penicillamine, an amino acid analogue of cysteine, has been shown to inhibit the transactivation of HIV-1 LTR by the transactivator protein, tat protein.
Chandra, P.   +9 more
core   +1 more source

Non-ceruloplasmin copper and urinary copper in clinically stable Wilson disease: Alignment with recommended targets

open access: yesJHEP Reports
Background & Aims: Wilson disease (WD) is caused by accumulation of copper primarily in the liver and brain. During maintenance therapy of WD with D-penicillamine, current guidelines recommend on-treatment ranges of urinary copper excretion (UCE) of ...
Peter Ott   +16 more
doaj   +1 more source

Metabolic balances of sulfur in patients with hepatolenticular degeneration and effect of the use of D-penicillamine Balanços metabólicos do enxôfre em pacientes com degeneração hepatolenticular e efeito da administração de D-penicilamina

open access: yesArquivos de Neuro-Psiquiatria, 1969
The metabolic balances of sulfur in two cases of hepatolenticular degeneration were studied. A positive balance was found in both cases; in one patient submitted to mixed diet, the average was significantly higher than the normal mean. The administration
Horacio M. Canelas   +2 more
doaj  

Comparative management practices of Wilson disease in Californian and Italian providers

open access: yesJournal of Health, Population and Nutrition
Background There is a scarcity of randomized and high-quality studies to aid clinicians in management and treatment of Wilson disease (WD). Even amongst society practice guidelines in North America and Europe, diagnosis and management of WD varies.
Sandy Vien   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy